These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 24534033)
1. MELAS: A Multigenerational Impact of the MTTL1 A3243G MELAS Mutation. Prasad M; Narayan B; Prasad AN; Rupar CA; Levin S; Kronick J; Ramsay D; Tay KY; Prasad C Can J Neurol Sci; 2014 Mar; 41(2):210-9. PubMed ID: 24534033 [TBL] [Abstract][Full Text] [Related]
2. [Evolution until death of two members of a family with A3243G mutation and MELAS phenotype versus diabetes mellitus]. Pérez López-Fraile MI; Barrena R; Montoya J; Marta E Neurologia; 2006; 21(6):327-32. PubMed ID: 16799910 [TBL] [Abstract][Full Text] [Related]
3. Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation. de Vries D; de Wijs I; Ruitenbeek W; Begeer J; Smit P; Bentlage H; van Oost B J Neurol Sci; 1994 Jun; 124(1):77-82. PubMed ID: 7931425 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial genetic analysis in a Chinese family suffering from both mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes and diabetes. Li W; Zhang W; Li F; Wang C Int J Clin Exp Pathol; 2015; 8(6):7022-7. PubMed ID: 26261593 [TBL] [Abstract][Full Text] [Related]
5. MERRF/MELAS overlap syndrome in a family with A3243G mtDNA mutation. Mongini T; Doriguzzi C; Chiadò-Piat L; Silvestri G; Servidei S; Palmucci L Clin Neuropathol; 2002; 21(2):72-6. PubMed ID: 12005255 [TBL] [Abstract][Full Text] [Related]
6. Clinical features of MELAS and its relation with A3243G gene point mutation. Zhang J; Guo J; Fang W; Jun Q; Shi K Int J Clin Exp Pathol; 2015; 8(10):13411-5. PubMed ID: 26722549 [TBL] [Abstract][Full Text] [Related]
7. [Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with the A3243G mutation of the tRNALeu(UUR) gene of mtDNA in native American haplogroup B2]. Delgado-Sánchez R; Zárate-Moysen A; Monsalvo-Reyes A; Herrero MD; Ruiz-Pesini E; López-Pérez M; Montoya J; Montiel-Sosa JF Rev Neurol; 2007 Jan 1-15; 44(1):18-22. PubMed ID: 17199225 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneous phenotypic manifestations of maternally inherited deafness associated with the mitochondrial A3243G mutation. Case report. Hoptasz M; Szczuciński A; Losy J Neurol Neurochir Pol; 2014; 48(2):150-3. PubMed ID: 24821643 [TBL] [Abstract][Full Text] [Related]
9. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Dubeau F; De Stefano N; Zifkin BG; Arnold DL; Shoubridge EA Ann Neurol; 2000 Feb; 47(2):179-85. PubMed ID: 10665488 [TBL] [Abstract][Full Text] [Related]
11. High frequency of migraine-only patients negative for the 3243 A>G tRNALeu mtDNA mutation in two MELAS families. Cevoli S; Pallotti F; La Morgia C; Valentino ML; Pierangeli G; Cortelli P; Baruzzi A; Montagna P; Carelli V Cephalalgia; 2010 Aug; 30(8):919-27. PubMed ID: 20656703 [TBL] [Abstract][Full Text] [Related]
12. Pathology of mitochondria in MELAS syndrome: an ultrastructural study. Felczak P; Lewandowska E; Stępniak I; Ołdak M; Pollak A; Lechowicz U; Pasennik E; Stępień T; Wierzba-Bobrowicz T Pol J Pathol; 2017; 68(2):173-181. PubMed ID: 29025253 [TBL] [Abstract][Full Text] [Related]
13. ["MELAS" (A3243G) mutation of mitochondrial DNA: a study of the relationships between the clinical phenotype in 19 patients and morphological and molecular data]. Laforêt P; Ziegler F; Sternberg D; Rouche A; Frachon P; Fardeau M; Eymard B; Lombès A Rev Neurol (Paris); 2000 Dec; 156(12):1136-47. PubMed ID: 11139730 [TBL] [Abstract][Full Text] [Related]
14. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. El-Hattab AW; Adesina AM; Jones J; Scaglia F Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523 [TBL] [Abstract][Full Text] [Related]
15. Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis. Sue CM; Crimmins DS; Soo YS; Pamphlett R; Presgrave CM; Kotsimbos N; Jean-Francois MJ; Byrne E; Morris JG J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):233-40. PubMed ID: 9703178 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype. Morgan-Hughes JA; Sweeney MG; Cooper JM; Hammans SR; Brockington M; Schapira AH; Harding AE; Clark JB Biochim Biophys Acta; 1995 May; 1271(1):135-40. PubMed ID: 7599199 [TBL] [Abstract][Full Text] [Related]
17. [Clinical, pathological and molecular biological characteristics of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episode in children]. Liu XL; Bao XH; Ma YN; Chang XZ; Qin J; Wu XR Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):130-5. PubMed ID: 23527980 [TBL] [Abstract][Full Text] [Related]
18. Familial recurrence of atypical symptoms in an extended pedigree with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Dougherty FE; Ernst SG; Aprille JR J Pediatr; 1994 Nov; 125(5 Pt 1):758-61. PubMed ID: 7965431 [TBL] [Abstract][Full Text] [Related]
19. The phenotypic spectrum of fifty Czech m.3243A>G carriers. Dvorakova V; Kolarova H; Magner M; Tesarova M; Hansikova H; Zeman J; Honzik T Mol Genet Metab; 2016 Aug; 118(4):288-95. PubMed ID: 27296531 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Sproule DM; Kaufmann P Ann N Y Acad Sci; 2008 Oct; 1142():133-58. PubMed ID: 18990125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]